CA
CVS icon

CapWealth Advisors’s CVS Health CVS Stock Holding History

CapWealth Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.4M Sell
326,034
-2,305
-0.7% -$178K 1.74% 23
2025
Q4 		$26.1M Buy
328,339
+9,430
+3% +$743K 1.78% 22
2025
Q3 		$24M Sell
318,909
-7,924
-2% -$543K 1.66% 24
2025
Q2 		$22.5M Sell
326,833
-35,021
-10% -$2.3M 2.22% 17
2025
Q1 		$24.5M Buy
361,854
+23,877
+7% +$1.43M 2.65% 11
2024
Q4 		$15.2M Buy
337,977
+5,391
+2% +$302K 1.66% 26
2024
Q3 		$20.9M Buy
332,586
+11,726
+4% +$684K 2.27% 16
2024
Q2 		$19M Sell
320,860
-366
-0.1% -$22.9K 2.39% 15
2024
Q1 		$25.6M Buy
321,226
+2,089
+0.7% +$160K 2.88% 11
2023
Q4 		$25.2M Sell
319,137
-2,923
-0.9% -$208K 3.07% 9
2023
Q3 		$22.5M Buy
322,060
+8,217
+3% +$582K 2.89% 8
2023
Q2 		$21.7M Buy
313,843
+18,558
+6% +$1.32M 2.65% 11
2023
Q1 		$21.9M Sell
295,285
-1,761
-0.6% -$148K 2.74% 9
2022
Q4 		$27.7M Buy
297,046
+31
+0% +$2.99K 3.25% 7
2022
Q3 		$28.3M Sell
297,015
-613
-0.2% -$60.7K 3.74% 3
2022
Q2 		$27.6M Buy
297,628
+3,862
+1% +$377K 3.33% 5
2022
Q1 		$29.7M Sell
293,766
-2,958
-1% -$311K 3.04% 6
2021
Q4 		$30.6M Buy
296,724
+557
+0.2% +$51.5K 3.11% 5
2021
Q3 		$25.1M Buy
296,167
+4,027
+1% +$337K 2.75% 6
2021
Q2 		$24.4M Buy
292,140
+10,310
+4% +$844K 2.65% 9
2021
Q1 		$21.2M Buy
281,830
+3,305
+1% +$241K 2.41% 12
2020
Q4 		$19M Sell
278,525
-2,825
-1% -$184K 2.27% 12
2020
Q3 		$16.4M Sell
281,350
-7,127
-2% -$443K 2.19% 17
2020
Q2 		$18.7M Buy
288,477
+5,196
+2% +$327K 2.65% 11
2020
Q1 		$16.8M Sell
283,281
-4,606
-2% -$307K 2.96% 11
2019
Q4 		$21.4M Buy
287,887
+3,860
+1% +$271K 2.69% 12
2019
Q3 		$17.9M Buy
284,027
+106,352
+60% +$6.3M 2.38% 15
2019
Q2 		$9.68M Buy
177,675
+7,671
+5% +$413K 1.38% 27
2019
Q1 		$9.17M Buy
170,004
+3,850
+2% +$238K 1.41% 26
2018
Q4 		$10.9M Buy
166,154
+22,960
+16% +$1.71M 1.91% 20
2018
Q3 		$11.3M Buy
143,194
+4,199
+3% +$300K 1.85% 17
2018
Q2 		$8.94M Buy
138,995
+116,920
+530% +$7.71M 1.6% 22
2018
Q1 		$1.37M Buy
+22,075
New +$1.58M 0.27% 56
2017
Q4 		– Sell
-4,165
Closed -$339K – 100
2017
Q3 		$339K Buy
4,165
+170
+4% +$13.4K 0.07% 87
2017
Q2 		$321K Buy
3,995
+100
+3% +$7.9K 0.06% 85
2017
Q1 		$306K Buy
+3,895
New +$311K 0.06% 88
2016
Q4 		– Sell
-1,670
Closed -$149K – 134
2016
Q3 		$149K Sell
1,670
-18,195
-92% -$1.72M 0.04% 95
2016
Q2 		$1.9M Buy
19,865
+321
+2% +$32K 0.46% 53
2016
Q1 		$2.03M Buy
19,544
+95
+0.5% +$9.24K 0.52% 51
2015
Q4 		$1.9M Buy
19,449
+559
+3% +$54.7K 0.46% 53
2015
Q3 		$1.82M Buy
18,890
+17,500
+1,259% +$1.84M 0.46% 54
2015
Q2 		$146K Buy
1,390
+1,304
+1,516% +$133K 0.03% 87
2015
Q1 		$9K Buy
+86
New +$8.7K ﹤0.01% 219

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CapWealth Advisors's CVS Position: Q1 2026 in Review

CapWealth Advisors reduced its CVS Health (CVS) stake by 0.7% in Q1 2026, selling an estimated $178K and leaving 326,034 shares worth $23.4M. The position accounts for 1.74% of the portfolio, ranked #23.

CapWealth Advisors first reported a position in CVS in Q1 2015 and has held it in 43 quarters since. The position peaked at $30.6M in Q4 2021. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • CapWealth Advisors held 326,034 shares of CVS Health worth $23.4M as of Q1 2026.
  • CapWealth Advisors sold 2,305 CVS Health shares in Q1 2026, an estimated $178K.
  • CVS Health made up 1.74% of CapWealth Advisors's portfolio in Q1 2026, its #23 holding.
  • CapWealth Advisors first reported a position in CVS Health in Q1 2015 and has held it in 43 quarters since.
  • CapWealth Advisors's CVS Health position peaked at $30.6M in Q4 2021.
  • 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on CapWealth Advisors's 13F filing for Q1 2026, filed 5 May 2026.